Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,325 public trials 1,974 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Recruiting

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

NCT06169371

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Illinois Chicago, Illinois, United States
  • Iowa Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Recruiting

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

NCT07368998

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Los Angeles Cancer Network Los Angeles, California, United States
  • Astera Cancer Care East Brunswick East Brunswick, New Jersey, United States
  • Instituto de Oncologia de Rosario Rosario, Santa Fe Province, Argentina
  • Centro Oncologico Korben Ciudad Autonoma Buenos Aires, Argentina
View all 30 locations
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

NCT06799065

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer Recurrent, +22 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions